Form 8-K Mereo BioPharma Group For: Mar 26
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall St slips on rising bond yields; Walmart results weigh
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Deutsche Bank calls Treasury buyback doubling similar to ’operation twist’
Mereo BioPharma director Jenkins won't seek re-election at 2026 meeting
March 27, 2026 6:16 AM EDTMereo BioPharma Group (NASDAQ: MREO) announced that Dr. Annalisa Jenkins will not stand for re-election as a director at the company's 2026 annual general meeting scheduled for May 14, 2026.
Jenkins informed the pharmaceutical company of her decision on March 26, 2026. She will continue serving... More
